About
Lindsay Androski is President and CEO of Roivant Social Ventures, a social impact investor and incubator focused on expanding healthcare access and improving health outcomes. In 2016, Ms. Androski joined the founding team at Roivant Sciences, where she built and led the deal team that successfully in-licensed or acquired 35 clinical-stage drug programs, and launched 16 subsidiary biotechs during her tenure, resulting in five new approved drugs to date.
Before joining Roivant, Ms. Androski served as a federal prosecutor in Alexandria, Virginia, focusing on cybercrime and national security cases, and as a trial lawyer and practice group co-chair at law firms in Washington D.C. and Los Angeles.
Ms. Androski is also a Trustee of the Massachusetts Institute of Technology, an Executive in Residence at Duke University (where she teaches on ESG investing), Board Chair of Incubate (a healthcare venture capital policy advocacy organization), and the proud mother of five children.
Episodes
-
November 15, 2022
Expanding Healthcare Access with Lindsay Androski
Lindsay Androski is President and CEO of Roivant Social Ventures, a social impact investor and incubator focused on expanding healthcare access and improving health outcomes. In 2016, Ms. Androski joined the founding team at Roivant Sciences, where she built and led the deal team that successfully in-licensed or acquired 35 clinical-stage drug programs, and launched […]